Danahy Kevin Patrick sold PLSE

February 13, 2026 · Form 4 insider transaction

Danahy Kevin Patrick sold 20,000 shares of Pulse Biosciences, Inc. at $23.53 per share, a transaction worth $470.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
20,000
Price
$23.53
Total value
$470.6K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after43,298
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.; The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $25.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR